WebWe have found that this cell-penetrating transformable peptide nanoparticle (CPTNP) was cytotoxic to NSCLC cells in the low-micromolar range and it synergized cisplatin cytotoxicity four-fold. WebCisplatin is a chemotherapy drug which is used to treat cancers including: sarcoma, …
cis-Diammineplatinum(II) Dichloride 15663-27-1 TCI AMERICA
WebSep 18, 2024 · National Center for Biotechnology Information WebFor sequential treatment of IFNβ and cisplatin, cells were treated first with or without IFNβ for 24~72 h and then washed twice with PBS to remove any residual IFNβ. Cells were subsequently treated with cisplatin (cisplatin or IFNβ+cisplatin) or left untreated (control or IFNβ) for 4 h (Western blotting for protein expression) and 24 h ... shark navigator powered lift-away
Cisplatin - an overview ScienceDirect Topics
WebJun 20, 2024 · Cisplatin [ cis- diamminedichloroplatinum (II) ( cis -DDP)] is one of the most successful anticancer agents employed today and is effective against a wide range of solid tumors ( 1 – 3 ), including neuroblastoma ( 4 ), the extracranial neoplasm most commonly diagnosed in childhood ( 5 ). WebCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is … WebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. shark navigator powered lift away 586